MX9702523A - Agentes liposomicos. - Google Patents

Agentes liposomicos.

Info

Publication number
MX9702523A
MX9702523A MX9702523A MX9702523A MX9702523A MX 9702523 A MX9702523 A MX 9702523A MX 9702523 A MX9702523 A MX 9702523A MX 9702523 A MX9702523 A MX 9702523A MX 9702523 A MX9702523 A MX 9702523A
Authority
MX
Mexico
Prior art keywords
metal ion
liposomal
moiety
membrane
liposomal agents
Prior art date
Application number
MX9702523A
Other languages
English (en)
Other versions
MXPA97002523A (es
Inventor
Martha Garrity
John Varadarajan
Alan David Watson
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of MXPA97002523A publication Critical patent/MXPA97002523A/es
Publication of MX9702523A publication Critical patent/MX9702523A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En la presente invencion se proporciona un agente liposomico que comprende liposomas que tienen unido a la membrana de los mismos un ion metálico, quelado, diagnosticamente o terapéuticamente efectivo, el agente quelante que se enlazan al ion metálico tiene una porcion de quelante macrocíclico que tiene unida a un solo átomo del anillo, de la misma, una porcion de asociacion a la membrana, lipofílica.
MX9702523A 1994-10-10 1995-10-09 Agentes liposomicos. MX9702523A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420390.8 1994-10-10
GB9420390A GB9420390D0 (en) 1994-10-10 1994-10-10 Liposomal agents
PCT/GB1995/002378 WO1996011023A1 (en) 1994-10-10 1995-10-09 Liposomal agents

Publications (2)

Publication Number Publication Date
MXPA97002523A MXPA97002523A (es) 1997-06-01
MX9702523A true MX9702523A (es) 1997-06-28

Family

ID=10762605

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702523A MX9702523A (es) 1994-10-10 1995-10-09 Agentes liposomicos.

Country Status (10)

Country Link
US (1) US6045821A (es)
EP (1) EP0785804B1 (es)
JP (1) JP4057646B2 (es)
CN (1) CN1168636A (es)
AU (1) AU3613695A (es)
CA (1) CA2200867A1 (es)
DE (1) DE69533197T2 (es)
GB (1) GB9420390D0 (es)
MX (1) MX9702523A (es)
WO (1) WO1996011023A1 (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
US6342598B1 (en) * 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
HUP0200483A3 (en) * 1999-03-11 2004-07-28 Fujisawa Pharmaceutical Co Liposome preparations
US6479300B1 (en) * 1999-03-15 2002-11-12 Millipore Corporation Metal loaded ligand bound membranes for metal ion affinity chromatography
US6379698B1 (en) * 1999-04-06 2002-04-30 Isis Pharmaceuticals, Inc. Fusogenic lipids and vesicles
EP1324996A2 (de) 2000-01-17 2003-07-09 Bayer CropScience AG Substituierte arylketone
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
EP1272507B1 (en) 2000-04-12 2005-06-29 Amersham Health AS Integrin binding peptide derivatives
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
AU2002303146A1 (en) * 2001-03-22 2002-10-08 The Administrators Of The Tulane Educational Fund Biaryl monomers and dendritic polymers derived therefrom
AU2002307343A1 (en) * 2001-04-17 2002-10-28 Genencor International, Inc. Method to bind enzyme to carrier using cationic copolymers and product produced thereby
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
NZ530156A (en) 2001-07-10 2007-04-27 Ge Healthcare As Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents
CA2455598A1 (en) * 2001-07-27 2003-02-13 Targesome, Inc. Lipid constructs as therapeutic and imaging agents
US7087212B2 (en) * 2001-08-17 2006-08-08 Mallinckrodt, Inc Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
US7238367B2 (en) * 2001-10-03 2007-07-03 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
US7381426B2 (en) * 2002-01-24 2008-06-03 Southwest Research Institute Targeted delivery of bioactive factors to the systemic skeleton
US20040034223A1 (en) * 2002-02-07 2004-02-19 Covalent Partners, Llc. Amphiphilic molecular modules and constructs based thereon
WO2003066646A2 (en) * 2002-02-07 2003-08-14 Covalent Partners, Llc Macrocyclic module compositions
EP1481268A4 (en) * 2002-02-07 2005-06-29 Covalent Partners Llc NANOFILM AND MEMBRANE COMPOSITIONS
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
US7184663B2 (en) * 2002-05-29 2007-02-27 Fujitsu Limited Optical ring network with hub node and method
CN1245153C (zh) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 一种维生素a脂质体及其制备方法
US20040106741A1 (en) * 2002-09-17 2004-06-03 Kriesel Joshua W. Nanofilm compositions with polymeric components
EP1466629A1 (en) * 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
WO2005030711A2 (en) * 2003-08-06 2005-04-07 Covalent Partners Llc Bridged macrocyclic module compositions
JP2007512221A (ja) * 2003-11-21 2007-05-17 富士フイルム株式会社 疎水性キレート化合物を含有するリポソームを含む造影剤
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
FR2875410B1 (fr) * 2004-09-23 2012-11-16 Guerbet Sa Composes de diagnostique pour le ciblage de recpteur a chimiokines
ATE493152T1 (de) * 2004-09-23 2011-01-15 Guerbet Sa Liposomale kontrastmittel für die cest-bildgebung
WO2006051732A1 (ja) * 2004-11-10 2006-05-18 Konica Minolta Medical & Graphic, Inc. 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム
DE102005018330B4 (de) 2005-04-20 2007-04-19 Siemens Ag System zur Erzeugung von CT-Bilddatensätzen und zur Bestrahlung eines Tumor-Patienten
NO20052428D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Kontrastmidler
US20070179094A1 (en) 2006-01-31 2007-08-02 Bayer Schering Pharma Ag Modulation of MDL-1 activity for treatment of inflammatory disease
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
CN1962683A (zh) * 2006-12-18 2007-05-16 张文芳 聚乙二醇修饰的甾醇共聚物及其应用
FR2914304B1 (fr) * 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
FR2914303A1 (fr) 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
WO2008134289A2 (en) * 2007-04-26 2008-11-06 Mallinckrodt Inc. High relaxivity coordinatively unsaturated lanthanide complexes
EP2348052A3 (en) 2007-09-17 2011-10-26 The Regents of The University of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
DE102008003615A1 (de) * 2008-01-09 2009-07-16 Magforce Nanotechnologies Ag Magnetische Transducer
WO2010021519A2 (en) * 2008-08-21 2010-02-25 Industry-Academic Cooperation Foundation, Yonsei University T1-t2 dual modal mri contrast agents
JP5657902B2 (ja) * 2010-03-17 2015-01-21 株式会社コスモステクニカルセンター ポリオキシアルキレンステロールエーテル誘導体及び／又はポリオキシアルキレンスタノールエーテル誘導体、及びそれを含有する外用剤組成物
EP2575896A2 (en) * 2010-05-26 2013-04-10 Erik Reimhult Magnetically responsive membrane structures
EP2684048B1 (en) 2011-03-11 2018-10-03 Board of Regents of the University of Nebraska Biomarker for coronary artery disease
AU2012292554B2 (en) 2011-08-10 2014-10-30 Magforce Ag Agglomerating magnetic alkoxysilane-coated nanoparticles
JP6368645B2 (ja) 2011-09-29 2018-08-01 ピーエルエックス オプコ インコーポレーテッド 胃腸管に沿った医薬の標的化放出のためのｐＨ依存性担体、それによる組成物、ならびにこれらの製造および使用
ES2733061T3 (es) * 2012-08-10 2019-11-27 Taiho Pharmaceutical Co Ltd Dispersión acuosa de liposomas encapsulantes de oxaliplatino estable y método para estabilización de la misma
EP2913065A4 (en) * 2012-10-25 2016-07-27 Imgt Co Ltd ULTRASONIC CONTRAST MEDIUM IN WHICH NANOPARTICLES CONTAINING A MEDICINE ARE COMBINED, AND METHOD FOR PREPARING THE SAME
EP2918262B1 (en) 2014-03-10 2023-08-09 PLS-Design GmbH Induction of antigen-specific tolerance by peripheral phagocytosis
GB2541835B (en) * 2015-01-21 2018-09-12 Pacira Pharmaceuticals Inc Multivesicular liposome formulations of tranexamic acid
US10265398B2 (en) * 2015-11-06 2019-04-23 Wisconsin Alumni Research Foundation Long-lived gadolinium based tumor targeted imaging and therapy agents
JP6983779B2 (ja) 2015-11-30 2021-12-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 非常に特異的な腫瘍細胞表面抗原を標的とするヒト抗体を用いた腫瘍特異的ペイロード送達及び免疫活性化
CN105693807B (zh) * 2016-01-25 2018-06-12 四川大学 新型脑靶向脂质材料及其在药物传递系统中的应用
US10751430B2 (en) * 2016-07-25 2020-08-25 Wisconsin Alumni Research Foundation Targeted radiotherapy chelates for in situ immune modulated cancer vaccination
EP3487543A1 (en) * 2016-07-25 2019-05-29 Wisconsin Alumni Research Foundation Radioactive phospholipid metal chelates for cancer imaging and therapy
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法
KR20230066149A (ko) 2020-08-07 2023-05-12 포티스 테라퓨틱스, 인크. Cd46을 표적화하는 면역접합체 및 이의 사용 방법
CN112180079B (zh) * 2020-09-25 2024-04-19 上海睿康生物科技有限公司 一种稳定的脂质体颗粒及其在免疫比浊检测中的应用
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603044A (en) * 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
GB8824593D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5053503A (en) * 1989-02-17 1991-10-01 Centocor Chelating agents
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
CA2102605A1 (en) * 1991-05-23 1992-11-24 Evan C. Unger Liposoluble compounds for magnetic resonance imaging
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5472605A (en) * 1994-03-10 1995-12-05 Hemasure, Inc. Filtration device useable for removal of leukocytes and other blood components
GB9407435D0 (en) * 1994-04-14 1994-06-08 Nycomed Salutar Inc Compounds

Also Published As

Publication number Publication date
JP4057646B2 (ja) 2008-03-05
EP0785804A1 (en) 1997-07-30
EP0785804B1 (en) 2004-06-23
DE69533197T2 (de) 2005-07-28
DE69533197D1 (de) 2004-07-29
CN1168636A (zh) 1997-12-24
WO1996011023A1 (en) 1996-04-18
JPH10507172A (ja) 1998-07-14
AU3613695A (en) 1996-05-02
CA2200867A1 (en) 1996-04-18
US6045821A (en) 2000-04-04
GB9420390D0 (en) 1994-11-23

Similar Documents

Publication Publication Date Title
MX9702523A (es) Agentes liposomicos.
EP0672430A3 (en) Duct for a humidifier.
AU4409696A (en) A breathable non-woven composite fabric
TR199501635A1 (tr) Solunum yolu ile alinan terapötik preparatlar.
HK1040711A1 (zh) 抗真菌劑及其製備方法和中間體
IL113902A (en) Respirator with a filter
ZA9510145B (en) Pocket filter
HRP950363A2 (en) Novel chemical compound, its preparation and use as a drug
ZA956265B (en) Herbicidal mixtures
AU2218895A (en) Chelant compounds
GB2209468B (en) Liposomes incorporating a photosensitising agent.
EP0684029A3 (en) Disposable diaper with sealable pocket.
EP0672761A3 (en) Use of a steel alloy.
GB9408814D0 (en) Compatible fuel additive concentrates
AU7708194A (en) Men's underwear
AU3216289A (en) Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
GB2296401B (en) Improved 'majority' filter
ZA952010B (en) Solid biocidal concentrates
EP0671355A3 (de) Bandablage.
HU9403540D0 (en) Solide water-soluble composition for producing solutions for vaginal irrigation
AU2904789A (en) Macrocyclic chelating agents and chelates thereof
AU109599S (en) A Housing for Assisting the Assembly of Jigsaw Puzzles
EP0174980A4 (en) Use of a manganese compound in the manufacture of a medicament for the treatment of hypothyroidism.
ZA200103910B (en) 1,4-Diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds.
GB9423303D0 (en) Medi sock